KDM3A and Alzheimer disease: According to bioinformatic analysis, the expression levels of JHDM1A, JHDM2A/2B, and JHDM3A/3B were significantly higher in the postmortem brain tissue of AD patients than in non-demented controls, whereas JHDM1B level was downregulated.